Javelin Pharmaceuticals, Inc., a specialized pharmaceutical enterprise, is involved in the exploration, advancement, and market introduction of products dedicated to the pain management sector, predominantly in the United States and Europe. Its product range focuses on addressing various pain disorders, including acute and recurring moderate to severe pain related to breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain.